A healthy heart beats 60 to 100 beats per minute, but when that rate slows down, patients require a pacemaker.

Abbott (NYSE: ABT) shares fell before hours today on fourth-quarter results that missed the consensus sales forecast.

University Hospital Southampton The twin wireless pacemaker system, known as AVEIR DR, is the first of its kind in the world Dr John Paisey, a consultant cardiologist at UHS, led the team which ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

The AVEIR leadless pacemaker remains one of the key drivers of the Rhythm Management business. By continuously innovating its approach to pacing, Abbott is helping transform care for millions of ...

The AVEIR dual chamber leadless pacemaker was implanted via the patient’s right internal jugular vein (instead of the femoral vein) so the patient could move easily and return to sports sooner.

Abbott announced the successful completion of the world's first in-human leadless left bundle branch area pacing (LBBAP) procedures using the company's investigational AVEIR Conduction System Pacing ...

The landmark procedures were part of the prospective Leadless CSP (Conduction System Pacing) feasibility study, which evaluated the acute safety and performance of the company’s investigational AVEIR ...

MUSKEGON — Trinity Health Muskegon recently achieved a significant milestone by successfully implanting AVEIR DR, the world’s ...

On Monday, an industry analyst highlighted several key developments in the medical device sector, noting increased investor interest ahead of Edwards Lifesciences' (NYSE:EW) Investor Day. The ...